Related Experiment Video
Updated: Jan 11, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Management of Asymptomatic Severe Aortic Stenosis: Current Evidence and Future Directions
Giulia Laterra1,2, Federica Agnello1,2, Orazio Strazzieri2
1Faculty of Medicine and Surgery, Università degli Studi di Enna "Kore", Piazza dell'Università, 94100 Enna, Italy.
Insights
Severe aortic stenosis (AS) management is complex. Early aortic valve replacement (AVR) may benefit high-risk patients, reducing hospitalizations but not necessarily mortality.
Area of Science:
- Cardiology
- Valvular Heart Disease
- Clinical Decision-Making
Background:
- Severe aortic stenosis (AS) is a common, progressive valvular heart disease.
- Management of asymptomatic severe AS is challenging, requiring individualized approaches.
- Optimal intervention timing for asymptomatic severe AS is debated.
Purpose of the Study:
- To review current strategies for managing asymptomatic severe aortic stenosis.
- To highlight the role of risk stratification in guiding intervention decisions.
- To discuss the implications of recent clinical trial data on management.
Main Methods:
- Systematic review of guidelines and recent randomized controlled trials.
- Analysis of risk stratification parameters including clinical, echocardiographic, biomarker, and advanced imaging data.
- Evaluation of outcomes related to early versus delayed aortic valve replacement (AVR).
Main Results:
- Guidelines recommend AVR for severe AS with reduced left ventricular ejection fraction (LVEF), irrespective of symptoms.
- For preserved LVEF, AVR decisions require comprehensive risk assessment.
- Recent trials show reduced heart failure hospitalizations with early AVR but mixed mortality benefits.
Conclusions:
- Individualized risk assessment is crucial for managing asymptomatic severe AS with preserved LVEF.
- Timely AVR in selected high-risk patients may improve long-term outcomes.
- Avoiding unnecessary procedures in low-risk patients is essential.
Abstract:
Systematic Severe aortic stenosis (AS) is a progressive disease and one of the most common valvular heart diseases in developed countries. The management of asymptomatic severe AS remains challenging and requires a tailored, patient-specific approach. Optimal timing of intervention in asymptomatic patients continues to be a matter of ongoing debate. In individuals with severe AS and reduced left ventricular ejection fraction (LVEF), both the ESC/EACTS and ACC/AHA guidelines recommend aortic valve replacement (AVR), regardless of symptom status. In contrast, for patients with preserved LVEF (≥50%), the decision to proceed with AVR must be individualized and based on a comprehensive risk assessment. Risk stratification plays a central role in guiding early intervention strategies and should incorporate clinical findings, echocardiographic parameters, biomarkers, and advanced imaging techniques such as cardiac magnetic resonance and computed tomography. Recent randomized controlled trials have yielded mixed results regarding the mortality benefit of early AVR but have consistently demonstrated a reduction in heart failure-related hospitalizations. Timely intervention in carefully selected high-risk patients may improve long-term outcomes, while avoiding unnecessary procedures in lower-risk individuals remains equally important.
More Related Videos
06:51Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
Published on: October 20, 2023
12:17Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Aneurysm III: Interprofessional Care
Mitral Stenosis IV: Nursing Management
Atherosclerosis III: Management
Aortic Regurgitation I: Introduction